Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy side effects most often begin within the first day or two of your starting dose, with nausea being the most commonly reported. For most people, the discomfort is mild to moderate and settles within one to two weeks as the body adjusts. That pattern tends to repeat (briefly) after each dose increase. Wegovy (semaglutide) is a prescription-only medicine; a clinical assessment is needed before starting, and your prescriber is the right person to talk through your individual risk of side effects before you begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer is quickly, often within hours of the first injection, though the peak of any discomfort usually arrives a day or so after the dose. This is a question our prescribers hear most weeks, and the honest answer involves two phases: what happens when you start, and what happens each time your dose steps up.
The GLP-1 receptor that semaglutide activates slows gastric emptying, which is part of how it reduces appetite. That same mechanism is responsible for the nausea and fullness that many people notice early on. The NHS medicines page for semaglutide lists nausea, vomiting, diarrhoea, constipation, indigestion and stomach pain as the most commonly reported effects, all GI-led, all linked to that slowing of digestion.
For the majority of people, these effects are temporary. They tend to be sharpest in the first few days after starting or increasing, then fade as the body acclimates. By week two, most people report the nausea has settled meaningfully, if not completely. If you are wondering how soon you get side effects from Wegovy, we cover that question in detail on a dedicated page. You can read more detail on what happens in the hours and days after a Wegovy dose if you want a closer look at that early window.
It is worth knowing that the starting dose of Wegovy (0.25mg) is deliberately low, not for weight-loss effect, but to reduce the likelihood of severe GI symptoms. The slow titration schedule exists for the same reason.
Often, yes, but usually less intensely than the first time. Each step up the semaglutide dose ladder (0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, and now up to 7.2mg following the MHRA's April 2026 approval of the higher-dose pen) can bring a brief return of nausea or digestive discomfort. It is the same physiological adjustment process, repeated at a higher level.
Most people find the recurrence is shorter and milder at each subsequent increase. Eating smaller meals, avoiding fatty or very rich food, staying well hydrated, and not lying down immediately after eating all help manage it. These are practical measures your prescriber will walk through with you, not just general advice, but things that make a real difference in the first weeks of each new dose.
For a broader look at how long these effects tend to persist across the full course of treatment, our page on how long Wegovy side effects last goes into more detail. And if you want to understand the full side-effect profile rather than just the timing, the complete Wegovy side effects guide covers it thoroughly.
The NHS semaglutide page also notes that side effects can be reported, and that telling your prescriber early means they can help manage them rather than leaving you to cope alone.
Most side effects do not require emergency care. But some do, and it matters to know the difference before you start treatment.
Seek urgent help for: severe and persistent stomach pain, especially pain that spreads to your back, with or without vomiting. This can be a sign of acute pancreatitis. The MHRA reinforced this in its January 2026 Drug Safety Update on GLP-1 receptor agonists, published on GOV.UK, which describes pancreatitis as an infrequent but potentially serious risk. Symptoms of gallbladder problems (sudden pain in the upper right abdomen, fever, jaundice) also warrant prompt medical review.
Other signs that should prompt a call to 999 or A&E rather than waiting: a serious allergic reaction (swelling of face, lips or throat, difficulty breathing), severe dehydration from persistent vomiting or diarrhoea, or sudden changes in vision if you have diabetes.
For anything less acute but still concerning, contact your prescriber or call 111. At nume, aftercare support is available seven days a week, details on how to reach us are on our contact page. Our clinical team is there precisely for these moments, not just at the point of prescription.
You can report any side effect you suspect is linked to Wegovy directly to the MHRA's Yellow Card scheme. You do not need a doctor to do this, patients report directly, and it contributes to ongoing safety monitoring of the medicine.
Not everyone has the same experience, and the variation is real. Factors that seem to influence both onset and intensity include how sensitive your digestive system is generally, whether you eat a large meal close to the injection, your hydration levels, and how quickly your dose is increased.
People who have previously had significant nausea with other medicines often find the early weeks of Wegovy harder. That is not a reason to avoid treatment, it is a reason to have that conversation with your prescriber first, so they can plan your titration carefully and know what to watch for.
More on the factors that influence how quickly side effects are felt is covered on a dedicated page if you want the specifics. There is also practical detail on exactly when side effects begin after starting Wegovy for those at the very beginning of treatment.
Wegovy is a prescription-only medicine licensed for weight management in adults, full eligibility information and what a consultation involves are on our treatment page. Our prescribers discuss individual side-effect risk and how to manage it as a core part of every consultation. Speak to our prescribers if you want to understand what your own experience is likely to look like before you commit to starting.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.